Dimerix phase III kidney disease trial strengthened by PARASOL data

Final data analysis from the Dimerix collaboration with PARASOL reinforces the company’s proteinuria-based endpoints in its phase III ACTION3 trial of lead drug DMX-200 in rare kidney disease Focal ...

Two-step excitation unlocks and steers exotic nanolight

An international team of researchers has developed a novel technique to efficiently excite and control highly-confined ...
Waco Tribune-Herald

Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the ...

Findings show that Telomir-1 restores the body's natural tumor suppressor defenses by reversing abnormal DNA methylation of MASPIN and RASSF1A - genes that help block invasion, limit metastasis, and i ...

How Nobel laureates uncovered the body’s immune watchdogs

For the Nobel laureates, the journey began in the 1980s with Shakaguchi’s discovery, and was furthered in the 1990s-2000s by ...
Android Central on MSN

I tested the iPhone Air, and it finally lets you choose your compromise

We've been sacrificing portability and maneuverability for the sake of features and battery life for years. Now, you can do ...

I tested a $400 Android phone with an E Ink like display, and it was boringly awesome

The TCL Nxtpaper 60 Ultra redefines 'Ultra,' prioritizing eye comfort and stylus performance over sheer power.

MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction

Closing adds $5 million in marketable securities, strengthens financial position, and complements MIRA’s advancing programs including Ketamir-2 and MIRA-55 MIAMI, FLORIDA / ACCESS Newswire / September ...